Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
2.110
+0.010 (0.48%)
At close: Nov 5, 2024, 4:00 PM
2.080
-0.030 (-1.42%)
After-hours: Nov 5, 2024, 4:41 PM EST
Standard BioTools Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Standard BioTools stock have an average target of 2.88, with a low estimate of 2.50 and a high estimate of 3.25. The average target predicts an increase of 36.49% from the current stock price of 2.11.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LAB stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $2.75 → $2.5 | Strong Buy | Maintains | $2.75 → $2.5 | +18.48% | Oct 31, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $3.5 → $2.75 | Strong Buy | Maintains | $3.5 → $2.75 | +30.33% | Aug 1, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates $3.5 | Strong Buy | Initiates | $3.5 | +65.88% | Apr 16, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $3.25 | Strong Buy | Initiates | $3.25 | +54.03% | Apr 4, 2024 |
| Keybanc | Keybanc | Buy Initiates $4 | Buy | Initiates | $4 | +89.57% | Jul 12, 2023 |
Financial Forecast
Revenue This Year
172.90M
from 106.34M
Increased by 62.59%
Revenue Next Year
195.78M
from 172.90M
Increased by 13.23%
EPS This Year
-0.46
from -0.94
EPS Next Year
-0.23
from -0.46
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 180.6M | 206.3M | 255.2M | |
| Avg | 172.9M | 195.8M | 236.6M | |
| Low | 166.6M | 186.2M | 215.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 69.8% | 19.3% | 30.3% | |
| Avg | 62.6% | 13.2% | 20.9% | |
| Low | 56.7% | 7.7% | 10.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -0.40 | -0.20 | -0.05 | |
| Avg | -0.46 | -0.23 | -0.08 | |
| Low | -0.53 | -0.25 | -0.09 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.